Maravai LifeSciences Holdings, Inc.
MRVI
$1.77
$0.052.91%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 75.33% | -1,432.62% | -15.96% | -17,926.87% | -381.55% |
| Total Depreciation and Amortization | 11.91% | 7.20% | 23.30% | 26.09% | 29.42% |
| Total Amortization of Deferred Charges | -11.44% | 2.17% | 2.06% | 2.92% | 13.61% |
| Total Other Non-Cash Items | -93.51% | 5,250.84% | 240.08% | -104.66% | 46.22% |
| Change in Net Operating Assets | -520.93% | -32.35% | -87.92% | -115.57% | 115.09% |
| Cash from Operations | -287.91% | -7.27% | -9.17% | -109.95% | -92.16% |
| Capital Expenditure | 65.18% | 45.72% | 61.88% | 28.00% | -170.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.44% | -219.87% | 325.09% | -81.94% | 132.01% |
| Cash from Investing | 61.78% | 42.27% | 74.41% | 93.91% | 30.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15,245.74% | -2.43% | -5.75% | -10.66% | -10.44% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -71.51% | -- | -- | -330.33% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -360.31% | 20.10% | 104.19% | 113.58% | 103.57% |
| Cash from Financing | -50,352.98% | 3.32% | 100.53% | 97.08% | 100.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,408.46% | 973.20% | 123.87% | -243.36% | -131.60% |